US5502187A
(en)
*
|
1992-04-03 |
1996-03-26 |
The Upjohn Company |
Pharmaceutically active bicyclic-heterocyclic amines
|
AU692484B2
(en)
*
|
1993-10-12 |
1998-06-11 |
Du Pont Pharmaceuticals Company |
1N-alkyl-N-arylpyrimidinamines and derivatives thereof
|
US6342501B1
(en)
|
1994-02-25 |
2002-01-29 |
The Regents Of The University Of Michigan |
Pyrrolo[2,3-d] pyrimidines as antiviral agents
|
PT757685E
(pt)
*
|
1994-04-29 |
2004-10-29 |
Pfizer |
Novas amidas ciclicas como incrementadores de libertacao de neurotransmissores
|
ATE159257T1
(de)
*
|
1994-05-03 |
1997-11-15 |
Ciba Geigy Ag |
Pyrrolopyrimidinderivate mit antiproliferativer wirkung
|
TW530047B
(en)
*
|
1994-06-08 |
2003-05-01 |
Pfizer |
Corticotropin releasing factor antagonists
|
US5646152A
(en)
*
|
1994-06-15 |
1997-07-08 |
Pfizer Inc. |
Methods of administering CRF antagonists
|
PL181895B1
(pl)
*
|
1994-06-16 |
2001-10-31 |
Pfizer |
Nowe pirazolo-i pirolopirydyny _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ PL PL PL PL
|
EP0729758A3
(fr)
*
|
1995-03-02 |
1997-10-29 |
Pfizer |
Pyrazolopyrimidines et pyrrolopyrimidines pour traiter les troubles neuronaux et autres maladies
|
AU716993B2
(en)
*
|
1995-05-12 |
2000-03-16 |
Neurogen Corporation |
Novel deazapurine derivatives; a new class of CRF1 specific ligands
|
US5644057A
(en)
*
|
1995-05-12 |
1997-07-01 |
Neurogen Corporation |
Deazapurine derivatives; a new class of CRF1 specific ligands
|
US5804685A
(en)
*
|
1995-06-07 |
1998-09-08 |
Neurogen Corporation |
Deazapurine derivatives: a new class of CRF1 specific ligands
|
US7067664B1
(en)
|
1995-06-06 |
2006-06-27 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
US6956047B1
(en)
|
1995-06-06 |
2005-10-18 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
US6403599B1
(en)
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
CA2223081C
(fr)
*
|
1995-06-07 |
2001-03-06 |
Pfizer Inc. |
Derives de pyrimidine heterocycliques a noyaux condenses
|
US5665721A
(en)
*
|
1995-06-07 |
1997-09-09 |
Abbott Laboratories |
Heterocyclic substituted cyclopentane compounds
|
US6143749A
(en)
*
|
1995-06-07 |
2000-11-07 |
Abbott Laboratories |
Heterocyclic substituted cyclopentane compounds
|
US6395733B1
(en)
|
1995-06-07 |
2002-05-28 |
Pfizer Inc |
Heterocyclic ring-fused pyrimidine derivatives
|
AU738304B2
(en)
*
|
1995-10-13 |
2001-09-13 |
Neurogen Corporation |
Certain pyrrolopyridine derivatives; novel CRF 1 specific ligands
|
US5955613A
(en)
*
|
1995-10-13 |
1999-09-21 |
Neurogen Corporation |
Certain pyrrolopyridine derivatives; novel CRF1 specific ligands
|
ATE243697T1
(de)
*
|
1995-12-08 |
2003-07-15 |
Pfizer |
Substitutierte heterozyclische derivate als crf antagonisten
|
US6992188B1
(en)
|
1995-12-08 |
2006-01-31 |
Pfizer, Inc. |
Substituted heterocyclic derivatives
|
US6664261B2
(en)
|
1996-02-07 |
2003-12-16 |
Neurocrine Biosciences, Inc. |
Pyrazolopyrimidines as CRF receptor antagonists
|
PT882051E
(pt)
*
|
1996-02-07 |
2002-04-29 |
Janssen Pharmaceutica Nv |
Tiofenopirimidinas
|
US6051578A
(en)
*
|
1996-02-12 |
2000-04-18 |
Pfizer Inc. |
Pyrazolopyrimidines for treatment of CNS disorders
|
NZ331647A
(en)
*
|
1996-03-26 |
2000-03-27 |
Du Pont Pharm Co |
Aryloxy- and arylthio-fused pyridines and pyrimidines and derivatives
|
US6166016A
(en)
*
|
1996-06-06 |
2000-12-26 |
Otsuka Pharmaceutical Factory, Inc. |
Amide derivatives
|
US6313124B1
(en)
|
1997-07-23 |
2001-11-06 |
Dupont Pharmaceuticals Company |
Tetrazine bicyclic compounds
|
DE69738197T2
(de)
*
|
1996-07-24 |
2008-07-17 |
Bristol-Myers Squibb Pharma Co. |
Azolotriazine und pyrimidine
|
US6060478A
(en)
*
|
1996-07-24 |
2000-05-09 |
Dupont Pharmaceuticals |
Azolo triazines and pyrimidines
|
US6191131B1
(en)
|
1997-07-23 |
2001-02-20 |
Dupont Pharmaceuticals Company |
Azolo triazines and pyrimidines
|
US6124289A
(en)
*
|
1996-07-24 |
2000-09-26 |
Dupont Pharmaceuticals Co. |
Azolo triazines and pyrimidines
|
US7094782B1
(en)
|
1996-07-24 |
2006-08-22 |
Bristol-Myers Squibb Company |
Azolo triazines and pyrimidines
|
CZ292806B6
(cs)
*
|
1996-08-06 |
2003-12-17 |
Pfizer Inc. |
Pyrido- nebo pyrimido-6,6- nebo -6,7-bicyklické deriváty, farmaceutické kompozice na jejich bázi
|
US5861398A
(en)
*
|
1996-08-26 |
1999-01-19 |
Alanex Corporation |
Benzoperimidine-carboxylic acids and derivatives thereof
|
TW477787B
(en)
*
|
1996-08-27 |
2002-03-01 |
Pfizer |
Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same
|
WO1998011075A1
(fr)
*
|
1996-09-16 |
1998-03-19 |
Du Pont Pharmaceuticals Company |
Pyrazinones et triazinones ainsi que leurs derives
|
IL129825A0
(en)
*
|
1996-11-27 |
2000-02-29 |
Pfizer |
Fused bicyclic pyrimidine derivatives
|
US5723608A
(en)
*
|
1996-12-31 |
1998-03-03 |
Neurogen Corporation |
3-aryl substituted pyrazolo 4,3-d!pyrimidine derivatives; corticotropin-releasing factor receptor (CRF1) specific ligands
|
AU6279598A
(en)
|
1997-02-18 |
1998-09-08 |
Neurocrine Biosciences, Inc. |
Biazacyclic CRF antagonists
|
US6313141B1
(en)
|
1997-06-13 |
2001-11-06 |
Neurogen Corporation |
2-aminoalkylaminoquinolines as dopamine D4 ligands
|
US5972945A
(en)
*
|
1997-06-13 |
1999-10-26 |
Neurogen Corporation |
2-aminoalkylaminoquinolines; dopamine receptor subtype specific ligands
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
US6613777B1
(en)
|
1998-03-06 |
2003-09-02 |
Chen Chen |
CRF antagonistic pyrazolo[4,3-b]pyridines
|
CA2326606A1
(fr)
*
|
1998-04-02 |
1999-10-14 |
Neurogen Corporation |
Derives aminoalkyle substitues de 9h-pyridino [2,3-b]indole et 9h-pyrimidino [4,5-b]indole
|
US6147085A
(en)
*
|
1999-04-01 |
2000-11-14 |
Neurogen Corporation |
Aminoalkyl substituted 9H-pyridino[2,3-b] indole and 9H-pyrimidino[4,5-b] indole derivatives
|
US6472402B1
(en)
|
1998-04-02 |
2002-10-29 |
Neurogen Corporation |
Aminoalkyl substituted 5,6,7,8-Tetrahydro-9H-Pyridino [2,3-B]indole derivatives
|
US6221875B1
(en)
|
1998-04-02 |
2001-04-24 |
Neurogen Corporation |
Substituted 9H-pyridino [2,3-B]indole and 9H-pyrimidino [4,5-B]indole derivatives: selective neuropeptide Y receptor ligands
|
JP2002510687A
(ja)
*
|
1998-04-02 |
2002-04-09 |
ニューロゲン コーポレイション |
アミノアルキル置換ピロロ[2,3−b]ピリジンおよびピロロ[2,3−d]ピリミジン誘導体:crf1レセプタのモジュレータ
|
AU3375999A
(en)
*
|
1998-04-02 |
1999-10-25 |
Neurogen Corporation |
Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino(2,3-b)indole and 5,6,7,8-tetrahydro-9h-pyrimidino(4,5-b)indole derivatives: crf1 specific ligands
|
US6984667B2
(en)
*
|
1998-04-08 |
2006-01-10 |
Theta Biomedical Consulting And Development Co. |
Synergistic proteoglycan compositions for inflammatory conditions
|
US7906153B2
(en)
*
|
1998-04-08 |
2011-03-15 |
Theta Biomedical Consulting & Development Co., Inc. |
Anti-inflammatory compositions for treating multiple sclerosis
|
US7799766B2
(en)
*
|
1998-04-08 |
2010-09-21 |
Theta Biomedical Consulting & Development Co., Inc. |
Composition for treating hormonally-dependent cancers
|
US20050220909A1
(en)
*
|
2004-03-30 |
2005-10-06 |
Theoharides Theoharis C |
Composition for protection against superficial vasodilator flush syndrome
|
US20080153761A1
(en)
*
|
1998-04-08 |
2008-06-26 |
Theoharides Theoharis C |
Compositions for protection against superficial vasodilator flush syndrome, and methods of use
|
JP4611524B2
(ja)
*
|
1998-06-02 |
2011-01-12 |
オーエスアイ・ファーマスーティカルズ・インコーポレーテッド |
ピロロ[2,3d]ピリミジン組成物およびその使用
|
US6878716B1
(en)
|
1998-06-02 |
2005-04-12 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptor and uses thereof
|
US6686366B1
(en)
|
1998-06-02 |
2004-02-03 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
US6194574B1
(en)
|
1998-06-09 |
2001-02-27 |
Neurogen Corporation |
Pyrido[2,3-b]indolizine derivatives and aza analogues thereof: CRF1 specific ligands
|
DE69908173T2
(de)
|
1998-11-12 |
2004-08-19 |
Neurocrine Biosciences, Inc., San Diego |
Crf rezeptor-antagonisten und darauf bezogene methoden
|
US6531475B1
(en)
|
1998-11-12 |
2003-03-11 |
Neurocrine Biosciences, Inc. |
CRF receptor antagonists and methods relating thereto
|
IL142893A0
(en)
*
|
1998-11-12 |
2002-04-21 |
Neurocrine Biosciences Inc |
Fused polyclic heterocyclic compounds and pharmaceutical compositions containing the same
|
KR20010102544A
(ko)
*
|
1999-03-11 |
2001-11-15 |
우에하라 아끼라 |
카르바모일 테트라히드로피리딘 유도체
|
EP1040831A3
(fr)
|
1999-04-02 |
2003-05-02 |
Pfizer Products Inc. |
Utilisation d'antagonistes du facteur de libération de la corticotropine pour la prévention de la mort subite
|
US6387894B1
(en)
|
1999-06-11 |
2002-05-14 |
Pfizer Inc. |
Use of CRF antagonists and renin-angiotensin system inhibitors
|
US6432989B1
(en)
|
1999-08-27 |
2002-08-13 |
Pfizer Inc |
Use of CRF antagonists to treat circadian rhythm disorders
|
JP2003510327A
(ja)
|
1999-09-30 |
2003-03-18 |
ニューロジェン・コーポレーション |
特定のアルキレンジアミンで置換された複素環
|
IL139197A0
(en)
|
1999-10-29 |
2001-11-25 |
Pfizer Prod Inc |
Use of corticotropin releasing factor antagonists and related compositions
|
US6525067B1
(en)
*
|
1999-11-23 |
2003-02-25 |
Pfizer Inc |
Substituted heterocyclic derivatives
|
US6680322B2
(en)
|
1999-12-02 |
2004-01-20 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptors and uses thereof
|
US7160890B2
(en)
|
1999-12-02 |
2007-01-09 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
US6664252B2
(en)
|
1999-12-02 |
2003-12-16 |
Osi Pharmaceuticals, Inc. |
4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
|
TWI271406B
(en)
|
1999-12-13 |
2007-01-21 |
Eisai Co Ltd |
Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
|
EA200300834A1
(ru)
*
|
2000-01-18 |
2004-02-26 |
Пфайзер Продактс Инк. |
Антагонисты фактора, высвобождающего кортикотропин
|
EP1293213A1
(fr)
*
|
2000-02-14 |
2003-03-19 |
Japan Tobacco Inc. |
Agents prophylactiques/therapeutiques contre le stress postoperatoire
|
US6613901B2
(en)
|
2000-03-08 |
2003-09-02 |
Neurogen Corporation |
2-aminoalkylaminoquinolines as dopamine D4 ligands
|
US20060223824A1
(en)
|
2000-11-28 |
2006-10-05 |
Wyeth |
Serotonergic agents
|
US20060287335A1
(en)
|
2000-11-28 |
2006-12-21 |
Wyeth |
Serotonergic agents for treating sexual dysfunction
|
US6680324B2
(en)
|
2000-12-01 |
2004-01-20 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptors and uses thereof
|
US6673802B2
(en)
|
2000-12-01 |
2004-01-06 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
JP4579497B2
(ja)
*
|
2000-12-01 |
2010-11-10 |
オーエスアイ・ファーマスーティカルズ・インコーポレーテッド |
アデノシンa1、a2a、およびa3受容体に特異的な化合物、ならびにそれらの使用
|
KR100897430B1
(ko)
*
|
2000-12-01 |
2009-05-14 |
오에스아이 파마슈티컬스, 인코포레이티드 |
아데노신 a₁, a₂a 및 a₃ 수용체에 특이적인 화합물및 그의 용도
|
GB0100622D0
(en)
|
2001-01-10 |
2001-02-21 |
Vernalis Res Ltd |
Chemical compounds V111
|
TWI312347B
(en)
|
2001-02-08 |
2009-07-21 |
Eisai R&D Man Co Ltd |
Bicyclic nitrogen-containing condensed ring compounds
|
MXPA03009738A
(es)
|
2001-04-27 |
2004-01-29 |
Eisai Co Ltd |
Pirazol [1,5-a] piridinas y medicinas que las contienen.
|
MXPA03010324A
(es)
|
2001-05-14 |
2004-02-17 |
Bristol Myers Squibb Pharma Co |
PIRAZINONAS, PIRIDINAS Y PIRIMIDINAS SUBSTITUIDAS COMO LIGANDOS DEL FACTOR DE LIBERACIoN DE CORTICOTROPINA.
|
IL144900A
(en)
|
2001-08-14 |
2013-12-31 |
Neurim Pharma 1991 |
Melatonin and drugs containing it for use in the treatment of primary insomnia, and the manufacture of those drugs
|
US6638981B2
(en)
|
2001-08-17 |
2003-10-28 |
Epicept Corporation |
Topical compositions and methods for treating pain
|
US7504407B2
(en)
|
2001-11-30 |
2009-03-17 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 and A3 receptors and uses thereof
|
CN101973998A
(zh)
|
2001-12-20 |
2011-02-16 |
Osi药物公司 |
吡咯并嘧啶A2b选择性拮抗剂化合物
|
JP4440642B2
(ja)
|
2001-12-20 |
2010-03-24 |
オーエスアイ・ファーマスーティカルズ・インコーポレーテッド |
ピリミジンA2b選択的アンタゴニスト化合物、それらの合成、及び使用
|
DE10163991A1
(de)
*
|
2001-12-24 |
2003-07-03 |
Merck Patent Gmbh |
Pyrrolo-pyrimidine
|
DE60326869D1
(de)
|
2002-10-22 |
2009-05-07 |
Eisai R&D Man Co Ltd |
7-phenylpyrazolopyridinverbindungen
|
US7176216B2
(en)
|
2002-10-22 |
2007-02-13 |
Eisai Co., Ltd. |
7-phenylpyrazolopyridine compounds
|
GR1004664B
(en)
*
|
2002-11-26 |
2004-09-02 |
Bionature E A Ltd |
The charakteristics and advantages of our invention are illustrated by the following description, methods and results of our research, attached figures and supporting references
|
PL377520A1
(pl)
|
2002-12-13 |
2006-02-06 |
Warner-Lambert Company Llc |
Pochodne pregabaliny przeznaczone do leczenia fibromialgii i innych zaburzeń
|
AR042667A1
(es)
|
2002-12-26 |
2005-06-29 |
Taisho Pharmaceutical Co Ltd |
Derivados de pirrolopirimidina y pirrolopiridina sustituidos con un grupo amino ciclico
|
WO2004064748A2
(fr)
*
|
2003-01-21 |
2004-08-05 |
Trustees Of Dartmouth College |
Compositions et procedes destines au traitement du cancer de l'ovaire
|
WO2004092170A2
(fr)
|
2003-04-09 |
2004-10-28 |
Biogen Idec Ma Inc. |
Triazolotriazines et pyrazolotriazines et leurs procedes de fabrication et d'utilisation
|
EP1633756B1
(fr)
|
2003-04-09 |
2008-12-24 |
Biogen Idec MA Inc. |
Antagonistes de recepteur d'adenosine a2a
|
EP1615931A1
(fr)
|
2003-04-09 |
2006-01-18 |
Biogen Idec MA Inc. |
Triazolopyrazines et procedes de preparation et d'utilisation ce celles-ci
|
US7160888B2
(en)
|
2003-08-22 |
2007-01-09 |
Warner Lambert Company Llc |
[1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
|
WO2005066182A1
(fr)
|
2004-01-06 |
2005-07-21 |
Taisho Pharmaceutical Co., Ltd. |
Derives de thienopyrimidine et de thienopyridine substitues par un groupe amino cyclique
|
RU2367663C2
(ru)
|
2004-01-06 |
2009-09-20 |
Тайсо Фармасьютикал Ко., Лтд. |
Производные пирролопиримидина и пирролотриазина
|
US20070270588A1
(en)
*
|
2004-03-05 |
2007-11-22 |
Taisho Pharmaceutical Co., Ltd. |
Pyrrolopyrimidine Derivatives
|
US7923043B2
(en)
*
|
2004-03-30 |
2011-04-12 |
Theta Biomedical Consulting & Development Co., Inc. |
Method for protecting humans against superficial vasodilator flush syndrome
|
JP2007161585A
(ja)
*
|
2004-06-25 |
2007-06-28 |
Taisho Pharmaceut Co Ltd |
環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体
|
JP2008538577A
(ja)
*
|
2005-04-22 |
2008-10-30 |
ワイス |
ジヒドロベンゾフラン誘導体およびその使用
|
JP2008538581A
(ja)
*
|
2005-04-22 |
2008-10-30 |
ワイス |
{[(2r)−7−(2,6−ジクロロフェニル)−5−フルオロ−2,3−ジヒドロ−1−ベンゾフラン−2−イル]メチル}アミン塩酸塩の結晶形態
|
CN101203218A
(zh)
*
|
2005-04-22 |
2008-06-18 |
惠氏公司 |
苯并呋喃基链烷胺衍生物和其作为5-ht2c激动剂的用途
|
CN101175740A
(zh)
*
|
2005-04-22 |
2008-05-07 |
惠氏公司 |
二氢苯并呋喃衍生物和其用途
|
TW200800959A
(en)
|
2005-06-10 |
2008-01-01 |
Wyeth Corp |
Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
|
RU2008135326A
(ru)
*
|
2006-03-24 |
2010-04-27 |
Вайет (Us) |
Терапевтические композиции для лечения депрессии
|
JP2009531443A
(ja)
*
|
2006-03-29 |
2009-09-03 |
フォールドアールエックス ファーマシューティカルズ インコーポレーティッド |
α−シヌクレイン毒性の抑制
|
EP2076515B1
(fr)
|
2006-09-20 |
2013-07-17 |
Eli Lilly And Company |
Composés de thiophène pyrazolopyrimidine
|
MY146388A
(en)
|
2006-09-20 |
2012-08-15 |
Lilly Co Eli |
Thiazole pyrazolopyrimidines as crfi receptor antagonists
|
CL2008000119A1
(es)
|
2007-01-16 |
2008-05-16 |
Wyeth Corp |
Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia.
|
US9555032B2
(en)
*
|
2007-06-13 |
2017-01-31 |
Research Development Foundation |
Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating CRF receptor signaling
|
WO2009104080A2
(fr)
|
2008-02-20 |
2009-08-27 |
Targia Pharmaceuticals |
Compositions pharmaceutiques actives sur le snc et méthodes d'utilisation
|
CN102007133B
(zh)
|
2008-04-15 |
2013-06-12 |
卫材R&D管理有限公司 |
3-苯基吡唑并[5,1-b]噻唑化合物
|
EP2291181B9
(fr)
|
2008-04-18 |
2013-09-11 |
University College Dublin National University Of Ireland, Dublin |
Utilisation de la captodiamine pour le traitement des symptômes de la dépression
|
WO2010066629A2
(fr)
*
|
2008-12-09 |
2010-06-17 |
F. Hoffmann-La Roche Ag |
Nouvelles azaindoles
|
US9050275B2
(en)
*
|
2009-08-03 |
2015-06-09 |
Theta Biomedical Consulting & Development Co., Inc. |
Methods of screening for and treating autism spectrum disorders and compositions for same
|
US9176146B2
(en)
*
|
2009-08-03 |
2015-11-03 |
Theta Biomedical Consulting & Development Co., Inc. |
Methods of treating autism spectrum disorders and compositions for same
|
AR078521A1
(es)
|
2009-10-08 |
2011-11-16 |
Eisai R&D Man Co Ltd |
Compuesto pirazolotiazol
|
GB201210686D0
(en)
|
2012-06-15 |
2012-08-01 |
Holsboermaschmeyer Neurochemie Gmbh |
V1B receptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level
|
WO2014078568A1
(fr)
|
2012-11-14 |
2014-05-22 |
The Johns Hopkins University |
Méthodes et compositions pour le traitement de la schizophrénie
|
CU24275B1
(es)
|
2013-02-22 |
2017-10-05 |
Pfizer |
Derivados de cicloalquilo pirrolo [2,3-d] pirimidina-4-il amino útiles como inhibidores de quinasas janus relacionadas y composiciones farmacéuticas que contienen tales compuestos
|
GB201310782D0
(en)
|
2013-06-17 |
2013-07-31 |
Max Planck Innovation Gmbh |
Method for predicting a treatment response to a CRHR1 antagonist and/or V1B antagonist in a patient with depressive and/or anxiety symptoms
|
EP3180344B1
(fr)
|
2014-08-12 |
2019-09-18 |
Pfizer Inc |
Dérivés de pyrrolo[2,3-d]pyrimidine utiles pour inhiber la janus kinase
|
US10344032B2
(en)
|
2014-09-17 |
2019-07-09 |
Pécsi Tudományegyetem |
Agents for treating neurogenic inflammation and neuropathic hyperalgesia related disorders
|
KR102665765B1
(ko)
*
|
2015-07-20 |
2024-05-10 |
젠자임 코포레이션 |
콜로니 자극 인자-1 수용체(csf-1r) 저해제
|
CN110337294B
(zh)
*
|
2016-11-18 |
2022-11-01 |
囊性纤维化基金会 |
作为cftr增效剂的吡咯并嘧啶
|
EP4175572A4
(fr)
|
2020-08-12 |
2024-03-27 |
Spruce Biosciences Inc |
Procédés et compositions pour traiter le syndrome des ovaires polykystiques
|
EP4267573A1
(fr)
|
2020-12-23 |
2023-11-01 |
Genzyme Corporation |
Inhibiteurs deutérés du récepteur du facteur 1 de stimulation des colonies (csp-1r)
|
US11708372B2
(en)
|
2021-11-19 |
2023-07-25 |
Spruce Biosciences, Inc. |
Crystalline composition of tildacerfont and methods of use and preparation thereof
|